Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions
HemorrhageBariatric SurgeryObesity, Morbid
Interventions
DRUG

Tranexamic Acid

At the time of incision, 1000mg of the drug would be given intravenous, followed by two postoperative doses of 1000mg eight hours apart.

OTHER

Normal Saline (Placebo)

At the time of incision, 10ml of the drug would be given intravenous, followed by two postoperative doses of 10ml eight hours apart.

Trial Locations (1)

75300

RECRUITING

Patel Hospital, Karachi

All Listed Sponsors
lead

Patel Hospital, Pakistan

OTHER